PO:10:149 | Efficacy of anifrolumab in a case of systemic lupus erythematosus with pulmonary involvement
Background. Pulmonary involvement in systemic lupus erythematosus (SLE) is a heterogeneous and usually non-severe complication, affecting 50–70% of patients (and up to 4–5% at disease onset). Pleuro-parenchymal manifestations include pleuritis (30%), interstitial lung disease (ILD, 1–15%), and lupu...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
PAGEPress Publications
2025-11-01
|
| Collection: | Reumatismo |
| Sujets: | |
| Accès en ligne: | https://www.reumatismo.org/reuma/article/view/2146 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|